Prabu Nambiar

Statistics

Publications

Citations

H-Index

Active since

2010

Affiliations

Pfizer (United States)(Current)

International Pharmaceutical Federation

University of Kansas

United States Food and Drug Administration

University of Saskatchewan

Prabu Nambiar is an author at Pfizer (United States) specializing in modified-release capsule bioequivalence, therapeutic equivalence evaluation, and pharmacy.

Publications per year

2010–2010

Publications

Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified-release products: Workshop summary report

Mei-Ling Chen, Vinod P. Shah, Derek Ganes et al. · European Journal of Pharmaceutical Sciences · 2010 · 24 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Challenges and Opportunities in Establishing Scientific and Regulatory Standards for Assuring Therapeutic Equivalence of Modified Release Products: Workshop Summary Report

Mei-Ling Chen, Vinod P. Shah, Derek Ganes et al. · The AAPS Journal · 2010 · 21 citations · Full text

Pharmacy, Pharmaceutics, Regulatory Pharmacy +17

Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary report

Mei-Ling Chen, Vinod P. Shah, Derek Ganes et al. · Clinical Therapeutics · 2010 · 12 citations

Pharmacy, Pharmaceutics, Pharmacology +17

1–3 of 3